A Phase 2 Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

This clinical trial is for adults who have blood cancer or precancerous conditions that are highly likely to turn into blood cancer.The purpose of this study is to answer the following primary questions:Can the investigational drug Orca-T be safely given to participants with blood cancers and...